A carregar...
DPP-4 Inhibition and the Path to Clinical Proof
In the 1990s it was discovered that the enzyme dipeptidyl peptidase-4 (DPP-4) inactivates the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). DPP-4 inhibition results in raised levels of the two incretin hormones which in turn result in lower...
Na minha lista:
| Publicado no: | Front Endocrinol (Lausanne) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6593050/ https://ncbi.nlm.nih.gov/pubmed/31275243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00376 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|